Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
Open Access Publication
Rights and Permissions
Meyer MA, Baer JM, Knolhoff BL, Nywening TM, Panni RZ, Su X, Weilbaecher KN, Hawkins WG, Ma C, Fields RC, Linehan DC, Challen GA, Faccio R, Aft RL, DeNardo DG. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance. Nat Commun. 2018 Mar 28;9(1):1250. doi: 10.1038/s41467-018-03600-6. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/. Copyright The Author(s) 2018
Meyer, Melissa A.; Baer, John M.; Knolhoff, Brett L.; Nywening, Timothy M.; Panni, Roheena Z.; Su, Xinming; Weilbaecher, Katherine N.; Hawkins, William G.; Ma, Cynthia; Fields, Ryan C.; Linehan, David C.; Challen, Grant A.; Faccio, Roberta; Aft, Rebecca L.; and DeNardo, David G., "Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance." Nature Communications. 9, (2018).